Humanigen is not currently accepting enquiries regarding lenzilumab™ for emergency use.
Humanigen's Phase III study in COVID-19 is now enrolling. For more information, visit StopStorm.com
See also:
Mayo Clinic Study of Humanigen’s Lenzilumab Shows Rapid Recovery and Discharge in Severe and Critical COVID-19 Patients (more information)
Humanigen Reports Additional Analysis of Lenzilumab in Severe and Critical COVID-19 Patients (more information)